Editorial: “Dysmetabolism, obesity and inflammation: three prominent actors in the drama of major neuropsychiatric disorders”

Editorial: “Dysmetabolism, obesity and inflammation: three prominent actors in the drama of major neuropsychiatric disorders”

Bibliographic Details
Main Authors:	Tommaso Cassano, Luca Steardo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-08-01
Series:	Frontiers in Neuroscience
Subjects:	Inflammation Obesity Alzheimer’s disease neuropsychiatric disorders dysmetabolism
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnins.2016.00368/full

Similar Items

Childhood and Adolescent Obesity with Somatic Indicators of Stress, Inflammation, and Dysmetabolism before and after Intervention: A Meta-Analysis
by: Konstantina Dragoumani, et al.
Published: (2023-08-01)

Dysmetabolic Nephropathies in Children
by: S.V. Kushnirenko
Published: (2012-02-01)

Sleeve gastrectomy improves lipid dysmetabolism by downregulating the USP20-HSPA2 axis in diet-induced obese mice
by: Wenjie Zhang, et al.
Published: (2022-12-01)

Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
by: Jasbir Makker, et al.
Published: (2015-01-01)

Clinical significance of cardiovascular dysmetabolic syndrome
by: Deedwania Prakash C
Published: (2002-01-01)

Overnutrition during Pregnancy and Lactation Induces Gender-Dependent Dysmetabolism in the Offspring Accompanied by Heightened Stress and Anxiety
by: Gonçalo M. Melo, et al.
Published: (2023-12-01)

Achilles Tendon Rupture and Dysmetabolic Diseases: A Multicentric, Epidemiologic Study
by: Francesco Oliva, et al.
Published: (2022-06-01)

Multiomics Profiling Reveals Signatures of Dysmetabolism in Urban Populations in Central India
by: Tanya M. Monaghan, et al.
Published: (2021-07-01)

Turbina oblongata Protects Against Oxidative Cardiotoxicity by Suppressing Lipid Dysmetabolism and Modulating Cardiometabolic Activities Linked to Cardiac Dysfunctions
by: Ochuko L. Erukainure, et al.
Published: (2021-05-01)

Non-invasive methods for iron overload evaluation in dysmetabolic patients
by: Paula Pessin Fábrega Branisso, et al.
Published: (2022-07-01)

Dysmetabolic Iron Overload Syndrome: Going beyond the Traditional Risk Factors Associated with Metabolic Syndrome
by: Sandra Maria Barbalho, et al.
Published: (2023-01-01)

Effect of a Low-Moderate Exercise Program on Dysmetabolism in Older Adults: Results of a Randomized Controlled Trial
by: Fernanda Velluzzi, et al.
Published: (2022-08-01)

Predicting the Risk of Diabetic Foot Ulcers From Diabetics With Dysmetabolism: A Retrospective Clinical Trial
by: Mingyang Jiang, et al.
Published: (2022-07-01)

Dysmetabolism and Sleep Fragmentation in Obstructive Sleep Apnea Patients Run Independently of High Caffeine Consumption
by: Sílvia V. Conde, et al.
Published: (2022-03-01)

Neuropsychiatric comorbidity in obesity: role of inflammatory processes
by: Nathalie eCastanon, et al.
Published: (2014-05-01)

The role of dysmetabolic iron overload syndrome in non-alcoholic fatty liver disease and carbohydrate metabolism disorders induction
by: N. N. Musina, et al.
Published: (2023-11-01)

Dysmetabolisms Can Affect Total Antioxidant Capacity (TAC) of Human Plasma: Determination of Reference Intervals of TAC by Way of CUPRAC-BCS Method
by: Enrico Prenesti, et al.
Published: (2021-01-01)

Neuropsychiatric Symptoms of Alzheimer's Disease and Caregiver Burden
by: Behnam Iravani, et al.
Published: (2022-07-01)

Omega-3 PUFA Responders and Non-Responders and the Prevention of Lipid Dysmetabolism and Related Diseases
by: Simona Serini, et al.
Published: (2020-05-01)

Association of caregiver demographic variables with neuropsychiatric symptoms in Alzheimer's disease patients for distress on the Neuropsychiatric Inventory (NPI)
by: Cláudia Godinho, et al.

Neuropsychiatric disorders correction in Alzheimer's disease
by: N. N. Koberskaya
Published: (2022-06-01)

Aspects of animal models for major neuropsychiatric disorders
by: Lefter Radu, et al.
Published: (2014-01-01)

Metabolic Footprint, towards Understanding Type 2 Diabetes beyond Glycemia
by: Ana F. Pina, et al.
Published: (2020-08-01)

Serum metabolomics profiling by proton nuclear magnetic resonance spectrometry of the response to single oral macronutrient challenges in women with polycystic ovary syndrome (PCOS) compared with male and female controls
by: Héctor F. Escobar-Morreale, et al.
Published: (2023-09-01)

Neuropsychiatric Inventory domains cluster into neuropsychiatric syndromes in Alzheimer's disease: A systematic review and meta‐analysis
by: Shaun Kuan Wei Hiu, et al.
Published: (2022-09-01)

Plasma‐derived biomarkers of Alzheimer's disease and neuropsychiatric symptoms: A community‐based study
by: Janina Krell‐Roesch, et al.
Published: (2023-07-01)

Cognitive and non-cognitive neuropsychiatric disorders in dementia and methods of their correction
by: E. G. Mendelevich
Published: (2017-07-01)

Neuropsychiatric symptoms as the main determinant of caregiver burden in Alzheimer's disease
by: Renata Kochhann, et al.

The association between caregiver distress and individual neuropsychiatric symptoms of dementia
by: Annibal Truzzi, et al.

Neuropsychiatric symptoms and executive function impairments in Alzheimer’s disease and vascular dementia: The role of subcortical circuits
by: Chan Tiel, et al.
Published: (2019-09-01)

Mitochondrial trafficking in neuropsychiatric diseases
by: Samineh Deheshi, et al.
Published: (2013-03-01)

Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study
by: Emily D. Clark, et al.
Published: (2023-07-01)

Perceived stress and depressive symptoms not neuropsychiatric symptoms predict caregiver burden in Alzheimer’s disease: a cross-sectional study
by: Manee Pinyopornpanish, et al.
Published: (2021-03-01)

Neuropsychiatric complications of 500 cases of hyperthyroidism
by: Moetamedi M, et al.
Published: (1998-07-01)

The Histaminergic System in Neuropsychiatric Disorders
by: Li Cheng, et al.
Published: (2021-09-01)

Network analysis of neuropsychiatric symptoms in Alzheimer’s disease
by: Grace J. Goodwin, et al.
Published: (2023-08-01)

Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
by: Ramon Cacabelos
Published: (2020-04-01)

Understanding neuropsychiatric symptoms in Alzheimer’s disease: challenges and advances in diagnosis and treatment
by: Andrew Pless, et al.
Published: (2023-09-01)

Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease
by: Kok Pin Ng, et al.
Published: (2021-01-01)

Letter to Editor: Neuropsychiatric Consequences of Deep Brain Stimulation in Patients with Chronic Movement Disorders
by: Seyed Kazem Malakouti, et al.
Published: (2016-07-01)